These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 4148246)

  • 1. [Possibilities of differential treatment of the chronic form of ischemic heart disease].
    Miasnikov LA; Metelitsa VI
    Ter Arkh; 1973; 45(6):8-21. PubMed ID: 4148246
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of beta-adrenergic blocking agents and anabolic steroids in ischemic heart disease].
    Girina NI
    Vrach Delo; 1979 Dec; (12):48-50. PubMed ID: 43030
    [No Abstract]   [Full Text] [Related]  

  • 3. [Beta-adrenergic blocking agents ATP and anabolic hormones in the treatment of ischemic heart disease].
    Smolenskiĭ VS; Abinder AA
    Sov Med; 1977 Jan; (1):44-8. PubMed ID: 15321
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of anabolic steroids and adrenergic beta receptor blockaders on the indicators of rheogram of the aorta and lungs in patients with ischemic heart disease].
    Sharlaĭ IR
    Vrach Delo; 1974 Aug; 0(8):15-7. PubMed ID: 4153197
    [No Abstract]   [Full Text] [Related]  

  • 5. [Statistical evaluation of a cooperative study toward investigation of the effectiveness of the coronary stimulant dilazep in ischemic heart disease. 4. Results of a summarizing evaluation with factor analysis and multiple regression analysis].
    Schneider VB; Feldmann U; von Brachel H; Schnitker J; Gelbhaar H
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1879-93. PubMed ID: 4155951
    [No Abstract]   [Full Text] [Related]  

  • 6. [Correction of hemodynamic and metabolic disorders in patients with ischemic heart disease].
    Bondarenko IP
    Vrach Delo; 1988 Mar; (3):31-4. PubMed ID: 3394292
    [No Abstract]   [Full Text] [Related]  

  • 7. [Differentiated therapy of patients with chronic coronary insufficiency].
    Miasnikov LA; Metelitsa VI
    Ter Arkh; 1969 Apr; 41(4):74-82. PubMed ID: 4191108
    [No Abstract]   [Full Text] [Related]  

  • 8. [Consumption of coronary vasodilator agents and beta blockaders in 2 Prague districts].
    Balda L; Mikolásek A; Kubát K; Kratochvíl J; Stika L
    Cesk Zdrav; 1977 May; 25(5):201-6. PubMed ID: 16700
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of ischemic heart disease with "coronary drugs" (author's transl)].
    Heinecker R
    MMW Munch Med Wochenschr; 1977 Jan; 119(1):7-10. PubMed ID: 13298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic possibilities of 3,4,5-trimethoxybenzoyl-epsilon-amino-caproic acid (C-3) in non-infarctual coronary pain syndrome].
    De' Thomatis M
    Minerva Med; 1974 Feb; 65(12):657-70. PubMed ID: 4150491
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of milurite in ischemic heart disease].
    Teslenko VG; Khimenko LP
    Vrach Delo; 1980 Oct; (10):18-21. PubMed ID: 7434694
    [No Abstract]   [Full Text] [Related]  

  • 12. [Intervention in ischemic heart disease and myocardial infarction. 3. Medical intervention].
    Pedersen A
    Ugeskr Laeger; 1982 Jul; 144(29):2156-64. PubMed ID: 6128809
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drugs for the management of chronic ischemic heart disease].
    Klotzbach M
    Pharmazie; 1979 Aug; 34(8):487-90. PubMed ID: 43982
    [No Abstract]   [Full Text] [Related]  

  • 14. [Statistical evaluation of a cooperative study toward investigation of the effectiveness of the coronary stimulant dilazep in ischemic heart disease. 3. Influence of the duration of therapy and co-medication on the therapeutic result. Secondary effects and discontinuation of therapy].
    Schneider VB; Feldmann U; von Brachel H; Schnitker J; Gelbhaar H
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1873-9. PubMed ID: 4155950
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mechanism of action of beta-adrenoblockaders in ischemic heart disease].
    Likhtenshteĭn IE; Evstratova IN; Il'iash MG
    Vrach Delo; 1986 Aug; (8):14-6. PubMed ID: 2877525
    [No Abstract]   [Full Text] [Related]  

  • 16. [Dynamic observations of tolerance to physical exercise in patients with ischemic heart disease during drug therapy].
    Lupanov VP
    Kardiologiia; 1975 Sep; 15(9):68-73. PubMed ID: 7699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of Fendilin on the exercise test in patients with coronary disease].
    Spiel R; Enenkel W
    Wien Med Wochenschr; 1976 Mar; 126(13-14):186-9. PubMed ID: 10680
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of cardiac glycosides and anabolic preparations on the indices of the blood oxygen balance and carbohydrate metabolism in ischemic heart disease patients in the initial (preclinical) stage of heart failure].
    Denisiuk VI; Shkliar MB
    Ter Arkh; 1984; 56(4):64-7. PubMed ID: 6729733
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of medical therapy on long-term survival in ischemic heart disease].
    Caruzzo C; Sechi A; Monti C; Campagna G; Spinnler MT
    Minerva Cardioangiol; 1984 Dec; 32(12):887-93. PubMed ID: 6152332
    [No Abstract]   [Full Text] [Related]  

  • 20. [Course of concomitant diseases in ischemic heart disease patients on long-term beta-blocker therapy].
    Zhuk AE; Broun LM; Mendelevich LA
    Klin Med (Mosk); 1986 Feb; 64(2):95-7. PubMed ID: 2871222
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.